[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hallux-valgus\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hallux-valgus":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,22,0,[8,41,67,89,116,145,166,192,221,251,305,327,355,378,400,430,464,489,510,531,554,580],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100641470","evaluation-of-the-impact-of-self-rehabilitation-after-foot-surgery-via-a-connected-application-100641470",false,"NCT07653828","Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected Application","M-First","Inclusion Criteria:\n\n* Age \\> 18 years and \\\u003C 85 years,\n* Patient, male or female, undergoing surgery for unilateral and isolated Hallux valgus with procedure of the 1st ray,\n* First-line surgery,\n* Persistent mobility of the metatarsophalangeal joint of the hallux,\n* Patient in possession of a smartphone or tablet,\n* Patient affiliated with or beneficiary of a social security scheme,\n* Patient who has signed the free and informed consent.\n\nExclusion Criteria:\n\n* Patient not having a smartphone or tablet,\n* Rheumatoid foot,\n* Hallux rigidus\u002FMTP1 osteoarthritis,\n* Gestures on the lateral rays\n* Surgical or traumatic history influencing MTP1 mobility.\n* Minors\n* Adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial decision or administrative;\n* Pregnant, breastfeeding or parturient woman; - Hospitalized without consent","ALL","18 Years","85 Years",{"count":20,"type":21},188,"ESTIMATED","INTERVENTIONAL",[24],"NA","Hallux valgus is the most common forefoot deformity and primarily affects women. Surgical treatment involves an osteotomy of the first metatarsal to reduce the M1-M2 angle. Often, an osteotomy of the first phalanx of the big toe is performed in conjunction to reduce the M1-P1 angle.\n\nOnce the deformity has been corrected, the second objective is to restore the foot's function, particularly mobility and plantar flexion strength. To achieve this, rehabilitation is prescribed, but inconsistently due to the lack of clear guidelines and limited patient participation, especially outside of the physiotherapist's scheduled appointments.\n\nContinuous passive range of motion exercises can accelerate the return to standard footwear and normal joint mobility. This study is based on the hypothesis that an application connected with rehabilitation exercises to be done outside of sessions with a physiotherapist reproduces this mechanism of continuous passive mobility. In this context, it is hoped that patients benefiting from self-rehabilitation of the foot via the connected application, in addition to traditional care with a physiotherapist, will achieve better postoperative mobility of the metatarsophalangeal joint of the hallux compared to traditional care with a physiotherapist in patients undergoing hallux valgus surgery, with an isolated procedure on the first ray.\n\nThe main objective is to compare the mobility of the metatarsophalangeal joint of the hallux 6 months after an operation for isolated hallux valgus by osteotomy in patients benefiting from optimized rehabilitation with a physiotherapist using a connected application compared to patients receiving standard care with a physiotherapist.",[27],"Hallux Valgus","RECRUITING","2026-06-12",{"date":31,"type":32},"2026-06-17","ACTUAL",{"date":34,"type":32},"2021-06-28",{"date":36,"type":21},"2026-12",{"name":38,"class":39},"Ramsay Générale de Santé","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":51,"studyType":52,"phases":4,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":66},"100636546","a-study-of-virtuguide-system-and-depuy-synthes-lapidus-implant-in-participants-undergoing-lapidus-procedure-100636546","NCT07567092","A Study of VIRTUGUIDE System and DePuy Synthes Lapidus Implant in Participants Undergoing Lapidus Procedure","VIRTUGUIDE™ SYSTEM REGISTRY","Inclusion criteria:\n\n* Participants, both male and female, \\>= 22 years old at the time of consent\n* Participants undergoing a primary Lapidus procedure for the correction of hallux valgus using the VIRTUGUIDE System (software + instruments) and who receive a compatible DePuy Synthes Lapidus implant\n* Participants must be able to read and understand questions and responses in an available translated language for patient reported outcomes (PROMs)\n* All primary Lapidus fixation implants are used on-label according to the implant IFU\u002FFDA cleared labeling\n* Participants who can speak, read, and comprehend the Institutional Review Board approved Informed Consent Document and are willing and able to provide informed patient consent for participation and have authorized the transfer of his\u002Fher information to DePuy Synthes\n\nExclusion criteria:\n\n* Participation in any other medical device or medicinal product study within the previous month. Participation in observational studies is allowed\n* In the opinion of the Principal Investigator, the subject is unable to comply with the requirements of the registry\n* Participant has known allergies to implant components\n* Participant presenting for a revision of a Lapidus procedure\n* Participant has existing hardware in the operative joint","22 Years",{"count":50,"type":21},100,"12 Months","OBSERVATIONAL","The purpose of this study is to assess the surgeon experience and surgery outcomes in participants undergoing index Lapidus procedure for the correction of hallux valgus (a foot deformity where the big toe angles outward towards the other toes, causing a painful bony bump at the base of the big toe joint) using the VIRTUGUIDE System and compatible DePuy Synthes Lapidus implants.",[27],"NOT_YET_RECRUITING","2026-06-04",{"date":58,"type":32},"2026-06-05",{"date":60,"type":21},"2026-05-15",{"date":62,"type":21},"2028-05-15",{"name":64,"class":65},"DePuy Synthes Products, Inc.","INDUSTRY",8,{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":74,"targetDuration":4,"studyType":22,"phases":76,"briefSummary":77,"conditions":78,"keywords":79,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":87,"locationsCount":40},"100568384","tourniquet-use-in-hallux-valgus-surgery-100568384","NCT06680518","Tourniquet Use in Hallux Valgus Surgery","Prospective, Randomized Study of Tourniquet Use in Hallux Valgus Surgery","Inclusion Criteria:\n\n* Patients over 18 who has been informed and has signed the consent form\n* Patient to be operated on for bilateral hallux valgus with no difference in the procedure performed between the 2 feet, the deformity must not differ by more than 10° (angle M1P1) between the 2 sides.\n* Surgery planned on the same day for both feet\n\nExclusion Criteria:\n\n* Arthritic hallux valgus requiring arthrodesis\n* Inflammatory pathology (rheumatoid arthritis, etc.)",{"count":75,"type":21},44,[24],"Prospective, single-center, randomized interventional clinical trial of tourniquet use in hallux valgus surgery. Patients will be their own controls.",[27],[80,81],"hallux valgus","tourniquet","2026-06-02",{"date":56,"type":32},{"date":85,"type":32},"2024-10-09",{"date":36,"type":21},{"name":88,"class":39},"Clinique Saint Jean, France",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":96,"sex":16,"minAge":17,"maxAge":97,"enrollmentInfo":98,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":100,"conditions":101,"keywords":103,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":4},"100638649","return-to-cross-country-skiing-and-other-physical-activities-after-arthrodesis-of-the-first-metatarsophalangeal-joint-100638649","NCT07610330","Return to Cross Country Skiing and Other Physical Activities After Arthrodesis of the First Metatarsophalangeal Joint","Retur Til Fysisk Aktivitet Etter Avstivning av stortåens Grunnledd","Inclusion Criteria:\n\n* Patients who has underwent arthrodesis of the first metatarsofalangeal joint because of hallux rigidus or severe hallux valgus\n* Patients at age 18-60 at the date of surgery\n* At least one year follow-up, and maximum 5 years since surgery.\n\nExclusion Criteria:\n\n* Non-Norwegian-speaking patients.\n* Impaired walking function.\n* Inability to cooperate.\n* Concomitant osteotomy of other metatarsals.\n* Revision arthrodeses.\n* Patients undergoing follow-up or evaluation for pseudoarthrosis.",true,"60 Years",{"count":99,"type":21},150,"Patients who have undergone arthrodesis of the first metatarsophalangeal joint due to hallux valgus or hallux rigidus are invited to participate in this study, which aims to investigate how the foot functions after this operation. Patients between 18 and 60 years of age at the time of surgery are eligible to participate. Questionnaires will be distributed to assess current sports function compared with function prior to surgery. Particular focus will be placed on function during cross-country skiing.",[102,27],"Hallux Rigidus",[104,105,106],"Return to sport","First metatarsophalangeal joint","Arthrodesis","2026-05-20",{"date":109,"type":32},"2026-05-27",{"date":111,"type":21},"2026-06",{"date":113,"type":21},"2027-12",{"name":115,"class":39},"Oslo University Hospital",{"id":117,"slug":118,"hasResults":11,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":4,"eligibilityCriteria":122,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":123,"targetDuration":4,"studyType":22,"phases":125,"briefSummary":127,"conditions":128,"keywords":130,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":40},"100640380","phase-2-sciatic-nerve-block-with-alx006-in-subjects-undergoing-bunionectomy-100640380","NCT07574385","Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy","A Phase 2, Randomized, Double-blind, Active-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, Efficacy and Pharmacodynamics of ALX006 for Postsurgical Pain Management When Administered as a Sciatic (in the Popliteal Fossa) Nerve Block in Subjects Undergoing a Bunionectomy","Inclusion Criteria:\n\n* Male or female, ages 18 or older at screening\n* American Society of Anesthesiologists (ASA) physical status 1, 2, or 3 (see Appendix 5)\n* Able to provide informed consent, adhere to the study schedule, and complete all study assessments\n* Primary surgical indication is related to a bunion deformity (i.e., hallux valgus) and subject is scheduled to undergo a primary unilateral distal metaphyseal osteotomy procedure (i.e., Austin procedure)\n* Indicated to undergo elective (i.e., not emergency) bunionectomy\n* Body Mass Index (BMI) ≥18 and \\\u003C40 kg\u002Fm2\n\nExclusion Criteria:\n\n* Allergy, hypersensitivity, intolerance, or contraindication to any of the study medications for which an alternative is not named in the protocol (e.g., amide-type local anesthetics, opioids, bupivacaine HCl, NSAIDs)\n* Concurrent painful physical condition (e.g. arthritis, fibromyalgia, cancer) that may require analgesic treatment with NSAIDs or opioids in the post dosing period for pain that is not strictly related to the surgery and which, in the Investigator's opinion, may confound the post dosing assessments\n* Inadequate sensory function of the foot\u002Fankle as assessed by the Investigator\n* History of, suspected, or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past two (2) years\n* Administration of an investigational drug within thirty (30) days or five (5) elimination half-lives of such investigational drug, whichever is longer, prior to study drug administration, or planned administration of another investigational product or procedure during the subject's participation in this study\n* Administration of any local anesthetic within 72 hours prior to administration of study drug, other than for pretreatment prior to a needle placement\n* Require additional local anesthetic other than study drug or lidocaine used for the Mayo field block or for pretreatment prior to a needle placement during the study period\n* Uncontrolled anxiety, psychiatric, or neurological disorder that, in the opinion of the Investigator, could interfere with study assessments or compliance\n* Currently pregnant, nursing, or planning to become pregnant during the study\n* Clinically significant medical disease that, in the opinion of the Investigator would make participation in a clinical study inappropriate. This includes diabetic neuropathy, coagulation or bleeding disorders, severe peripheral vascular disease, renal insufficiency, hepatic dysfunction, glucose-6-phosphate dehydrogenase deficiency or other conditions that would constitute a contraindication to participation in the study\n* Confirmed clinically significant vital sign or ECG abnormality, including QTcF \\> 450 msec at Screening\n* Has any of the following laboratory abnormalities during Screening (1 retest permitted):\n\n  1. History of liver cirrhosis, having an aspartate aminotransferase \\>3x the upper limit of normal (ULN), or having an alanine aminotransferase \\> 3x ULN.\n  2. Severe kidney function impairment as defined by estimated glomerular filtration rate (eGFR) by CKD-EPI 2021 equation \\\u003C30 mL\u002Fmin\u002F1.73 m²or on dialysis.\n  3. Platelet count \\\u003C 100,000\u002FuL, hemoglobin \\\u003C 12 g\u002FdL, or hematocrit \\\u003C 35%.\n* Currently on a gabapentinoid (e.g., gabapentin, pregabalin \\[Lyrica\\]) or a serotonin-norepinephrine reuptake inhibitor (SNRI) with recognized analgesic properties (e.g., duloxetine \\[Cymbalta\\]) that cannot be discontinued within 30 days before surgery. Other agents with documented efficacy in modulating acute or chronic pain may be excluded at the discretion of the Investigator in consultation with the Sponsor Medical Monitor. Selective serotonin reuptake inhibitors (SSRIs) are not excluded under this criterion.\n* Current use of systemic glucocorticoids within thirty (30) days of randomization in this study\n* Use of dexmedetomidine HCl or clonidine within three (3) days of study drug administration\n* Any use of marijuana (including tetrahydrocannabinol (THC) and cannabidiol (CBD)) within thirty (30) days prior to randomization, or planned use during the study.\n* Chronic opioid use within thirty (30) days prior to randomization (average ≥30 oral morphine mg equivalents\u002Fday)",{"count":124,"type":21},60,[126],"PHASE2","This is a Phase 2, randomized, double-blind, active-controlled, dose-escalation study evaluating the safety, pharmacokinetics, efficacy, and pharmacodynamics of ALX006, an extended-release bupivacaine formulation, administered as a single-dose sciatic nerve block in the popliteal fossa in adult subjects undergoing primary unilateral bunionectomy. Approximately 60 subjects will be enrolled across 3 sequential dose cohorts (100 mg, 150 mg, 200 mg ALX006), with each cohort comparing ALX006 against MARCAINE 0.25% (bupivacaine HCl 50 mg) as the active comparator at a 3:1 randomization ratio. Dose escalation between cohorts is governed by an Independent Data Monitoring Committee.",[27,129],"Bunionectomy",[131,132,133,134,135],"ALX006","Bupivacaine","Popliteal fossa nerve block","Analgesia","Post-operative analgesia","2026-05-04",{"date":138,"type":32},"2026-05-07",{"date":140,"type":32},"2026-03-10",{"date":142,"type":21},"2026-08",{"name":144,"class":65},"Rebel Medicine Inc",{"id":146,"slug":147,"hasResults":11,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":80,"eligibilityCriteria":151,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":152,"enrollmentInfo":153,"targetDuration":4,"studyType":22,"phases":155,"briefSummary":156,"conditions":157,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":160,"completionDateStruct":162,"leadSponsor":164,"locationsCount":40},"100506901","pilot-study-of-percutaneous-correction-of-hallux-valgus-100506901","NCT05880407","Pilot Study of Percutaneous Correction of Hallux Valgus","Pilot Study of Percutaneous Correction of Hallux Valgus: Clinical-functional Evaluation of Outcome Randomized Study","Inclusion Criteria:\n\n* Patients of both sexes with adult hallux valgus with indication for corrective surgical treatment\n* HVA (hallux valgus angle): 20°-40°\n* IMA (intermetatarsal angle): 10°-20°\n\nExclusion Criteria:\n\n* Patients with instability of the first metatarsophalangeal joint\n* Patients with severe morphostructural alterations or other pathologies in the foot and lower limb\n* patients requiring additional surgical procedures\n* patients with severe vascular and neurological systemic pathologies\n* systemic pathologies that may impair bone consolidation","65 Years",{"count":154,"type":21},40,[24],"This is a pilot study with a randomized controlled design.",[27],"2026-04-28",{"date":136,"type":32},{"date":161,"type":32},"2022-02-22",{"date":163,"type":21},"2026-12-31",{"name":165,"class":39},"Istituto Ortopedico Rizzoli",{"id":167,"slug":168,"hasResults":11,"nctId":169,"briefTitle":170,"officialTitle":171,"acronym":4,"eligibilityCriteria":172,"healthyVolunteers":11,"sex":16,"minAge":173,"maxAge":174,"enrollmentInfo":175,"targetDuration":4,"studyType":22,"phases":177,"briefSummary":178,"conditions":179,"keywords":181,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":40},"100634319","the-hyalex-mtp-study-100634319","NCT07538141","The Hyalex MTP Study","The Hyalex First-in-Human Study - A Prospective, Single-Arm, Feasibility Study of the HYALEX SLALOM MTP Hemiarthroplasty Implant","Inclusion Criteria:\n\n1. 21-75 years;\n2. Body Mass Index (BMI) ≤ 38;\n3. Degenerative or post-traumatic arthritis of the first metatarsal joint with ICRS grade 2, 3, or 4;\n4. Pre-operative VAS pain score of \\>40;\n5. Presence of good bone stock, without need for bone graft\n\nExclusion Criteria:\n\n1. Known allergy to polyurethanes, bone cement, acrylic, or titanium;\n2. Due to anatomy and\u002For lesion location, inability to position the implant flush or slightly proud relative to the articular surface precluding proper device placement;\n3. Lack of 2mm of vital bone on all sides of implant site;\n4. Cartilage lesions on the phalanx of ICRS Grade 3 - 4 opposite the lesion intended for treatment;\n5. Additional ipsilateral lower limb (hip, knee, ankle, or foot) pathology that requires active treatment (e.g., surgery, brace);\n6. Bilateral degenerative or post-traumatic arthritis of the MTP joints that would require simultaneous treatment of both MTP joints;\n7. Previous cheilectomy resulting in inadequate bone stock;\n8. Diagnosis of gout;\n9. Hallux varus to any degree or hallux valgus \\>20;\n10. Hyper mobility at proximal metatarsal joint;\n11. Interphalangeal angle \\>15","21 Years","75 Years",{"count":176,"type":21},20,[24],"The HYALEX SLALOM MTP Hemiarthroplasty System consists of a synthetic implant designed to replace the distal metatarsal surface of the great toe for treatment of arthritis . The system is composed of the HYALEX MTP Implant and instrumentation. The implant consists of the HYALEX Cartilage material bonded to a titanium backing.",[27,180,102],"Hallux Limitus",[182],"Arthritis","2026-04-13",{"date":185,"type":32},"2026-04-20",{"date":187,"type":32},"2025-10-01",{"date":189,"type":21},"2027-12-31",{"name":191,"class":65},"Hyalex Orthopaedics, Inc.",{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":199,"targetDuration":4,"studyType":22,"phases":200,"briefSummary":201,"conditions":202,"keywords":203,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":219,"locationsCount":40},"100536236","hallux-valgus-correction-using-the-metal-screw-or-the-human-allogeneic-cortical-bone-screw-shark-screw-100536236","NCT06262204","Hallux Valgus Correction Using the Metal Screw or the Human Allogeneic Cortical Bone Screw (Shark Screw).","Clinical and Radiological Comparison of Hallux Valgus Correction Using the Metal Screw or the Human Allogeneic Cortical Bone Screw, a Prospective Study","Inclusion Criteria:\n\n* between 18 and 85\n* confirmed Hallux Valgus\n\nExclusion Criteria:\n\n* \\\u003C18 years and \\>85 years\n* Known underlying oncological disease\n* Pregnant women or breastfeeding mothers\n* Alcohol and drug abuse\n* Foreseeable compliance problems\n* Foreseeable loss of responsibility as a study doctor\n* Neoplastic diseases\n* Active osteomyelitis\n* Ulcerations in the area of the skin of the surgical site\n* Immunosuppressive medication that cannot be discontinued",{"count":154,"type":21},[24],"The goal of this clinical trial is to compare the treatment of Hallux Valgus using the conventional method (metal screw) with the new method (human allogeneic cortical bone screw (Shark Screw®) in adult patients with confirmed Hallux Valgus.\n\nThe main questions it aims to answer are:\n\nCan the new method obtain comparable results as the conventional method in regard to union rate and time to union? Are the number of complications lower with the new method? Participants will be operated either with the metal screw or with the Shark Screw®. The assignment to the groups is randomized.",[27],[27,204,205,206,207,208,209,210,211],"human allogeneic cortical bone screw","Shark Screw®","HVA","IMA","AOFAS","time to union","union rate","FFI","2026-03-29",{"date":214,"type":32},"2026-04-02",{"date":216,"type":21},"2026-12-01",{"date":218,"type":21},"2028-12-31",{"name":220,"class":39},"Orthopedic Hospital Vienna Speising",{"id":222,"slug":223,"hasResults":11,"nctId":224,"briefTitle":225,"officialTitle":226,"acronym":227,"eligibilityCriteria":228,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":174,"enrollmentInfo":229,"targetDuration":4,"studyType":22,"phases":231,"briefSummary":232,"conditions":233,"keywords":235,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":242,"lastUpdatePostDateStruct":243,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":40},"100530348","the-effects-of-various-concentrations-of-ropivacaine-on-the-onset-and-duration-of-ankle-blocks-100530348","NCT06185608","The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks","The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ultrasound-guided Ankle Blocks in Patients Undergoing Hallux Valgus Repair Surgery - a Randomized, Double-blinded, Parallel-group Interventional Study","ROADS","Inclusion Criteria:\n\n* Provide signed and dated informed consent\n* Age 18 up to and including 75 years, scheduled for elective forefoot surgery for hallux valgus repair, with or without one or more of the following: minor toe procedures, osteotomies, arthrodesis or toe extensor\u002Fflexor procedures, under unilateral ankle block at ZOL Genk\n* ASA physical I-II-III\n* Able to ambulate (ability to walk independently, with or without assistive devices)\n* Able to learn and perform study sensory and motor assessment by exhibiting sensitivity to pinprick, cold, and light touch (tested beforehand with pinprick\u002Fcold\u002F light touch sensation test) as the patient will have to perform these sensory and motor assessments by him\u002Fherself at home at postoperative day 0 to 2\n\nExclusion Criteria:\n\n* Language barrier\n* Preexisting lower extremity neuropathy\n* Contraindications to ankle block (local infection, edema, burn, soft tissue trauma, or distorted anatomy with scarring in the area of block placement)\n* Contraindications for use of NSAIDs\n* Allergy to local anesthetics\n* Uncontrolled anxiety, psychiatric or neurological disorder that might interfere with study assessment\n* Weight below 50 kg based on a maximum dose of 3 mg\u002Fkg ropivacaine and a maximum dose of 150 mg ropivacaine.\n* Preoperative use of opioids or gabapentin less than 3 days before surgery\n* Contraindications for use of paracetamol\n* Contraindications for use of tramadol",{"count":230,"type":21},174,[24],"Peripheral nerve blocks are essential in ensuring effective regional anesthesia and postoperative analgesia in forefoot surgery for hallux valgus repair, with or without minor concomitant toe procedures. Many factors influence the onset and duration of peripheral nerve blocks. In the advent of ultrasound-guided nerve blocks, the accuracy in administering LA has significantly improved, potentially reducing the required dosage, which is also associated with less risk for toxicity. However, the effect of the concentration of LA on the onset time and duration of ultrasound-guided ankle blocks for forefoot surgery has not yet been studied. This poses a clinically relevant dilemma regarding the necessity of administering lower or higher concentrations of ropivacaine to achieve a clinically relevant faster onset time and longer duration of an ankle block.",[27,234],"Anesthesia",[236,237,238,239,240,241],"Ropivacaine","Peripheral Nerve Block","Locoregional anesthesia","Onset","Duration","Sensory block","2026-03-19",{"date":244,"type":32},"2026-03-24",{"date":246,"type":32},"2025-05-22",{"date":248,"type":21},"2027-10-01",{"name":250,"class":39},"Ziekenhuis Oost-Limburg",{"id":252,"slug":253,"hasResults":11,"nctId":254,"briefTitle":255,"officialTitle":256,"acronym":4,"eligibilityCriteria":257,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":258,"targetDuration":4,"studyType":22,"phases":260,"briefSummary":261,"conditions":262,"keywords":280,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":296,"lastUpdatePostDateStruct":297,"startDateStruct":299,"completionDateStruct":301,"leadSponsor":303,"locationsCount":40},"100481933","performance-and-safety-evaluation-of-inion-compresson-screw-in-foot-and-ankle-surgeries-pmcf-investigation-100481933","NCT05555459","Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation","The Performance and Safety Evaluation of Bioabsorbable Headless Inion CompressOn Screws in Selected Fracture, Osteotomy and Artrodesis Surgeries of the Foot and Ankle","Inclusion Criteria:\n\n1. Read the patient information bulletin on the study and signed the patient consent form\n2. Adult patient (over 18-year-old)\n3. Suitable and in need for surgical lower limb operation listed in the indications of this study that requires fastening of bone structures with screws (or an alternative attachment method) in the ankle or foot area, according to a statement of the investigator surgeon\n4. Ability to fill in questionnaires.\n5. Willingness to comply with rehabilitation instructions.\n6. Availability for follow-up visits.\n\nExclusion Criteria:\n\n1. Active infection\n2. Patient conditions including limited blood supply (e.g. patients with severe circulatory disorder of the lower limb\n3. Patient conditions including insufficient quality or quantity of bone (diagnosed osteoporosis, conditions causing secondary osteoporosis e.g. diabetes, rheumatism, eating disorder)\n4. Patient conditions where patient cooperation cannot be guaranteed (alcohol use, drug abuse etc.)\n5. High-load bearing indications (e.g., diaphyseal fractures of long bones) unless used in conjunction with traditional rigid fixation\n6. Patients with significant neuropathy\n7. Pregnancy\n8. Patients who refuse to participate\n9. Lower limb tumor or metastasis\n10. Complex Regional Pain Syndrome (CRPS) in operated foot",{"count":259,"type":21},125,[24],"The study in question is a post market clinical follow up (PMCF) study to evaluate the safety and performance of bioabsorbable headless compression screw Inion CompressOn in selected fracture, osteotomy and arthrodeses operations of the foot and ankle. The study recruits 125 adult patients who meet the acceptance criteria. The follow-up time for each study patient is 4 years. The study is a single center single group study which is conducted in Tampere University Hospital (TAYS) in Finland. The main focus of the study in terms of performance is to evaluate the bone healing\u002Fossification of operated areas. The main focus of the study in terms of safety is to evaluate the occurrence of adverse events and required revision surgeries that are or might be related to the study device.",[263,264,265,266,267,268,269,270,271,272,273,274,275,276,277,102,27,278,279],"Medial Malleolus Fracture","Lisfranc Injury","Lisfranc Fracture","Talus Fracture","Calcaneus Fracture","Navicular Fracture","Deformity, Foot","Ankle Fractures","Foot Fracture","Fractures, Bone","Fracture of Foot","Foot Deformities","Foot Injury","Feet Deformity Tarsus","Metatarsalgia","Deformity of Toe","Deformity of Foot",[281,282,283,284,285,286,287,288,289,290,291,292,293,294,295],"bioabsorbable screw","compression screw","headless screw","orthopaedic screw","bone fixation","bioabsorbable screw study","resorbable","biodegradable","bioabsorbable","fracture fixation with resorbable implants","inion","post-market follow-up study","orthopedic bone fixation","arthrodesis","osteotomy","2026-03-11",{"date":298,"type":32},"2026-03-13",{"date":300,"type":32},"2023-03-07",{"date":302,"type":21},"2032-04-30",{"name":304,"class":65},"Inion Oy",{"id":306,"slug":307,"hasResults":11,"nctId":308,"briefTitle":309,"officialTitle":310,"acronym":311,"eligibilityCriteria":312,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":152,"enrollmentInfo":313,"targetDuration":4,"studyType":22,"phases":315,"briefSummary":316,"conditions":317,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":318,"lastUpdatePostDateStruct":319,"startDateStruct":321,"completionDateStruct":323,"leadSponsor":325,"locationsCount":40},"100624464","immediate-effect-of-taping-on-foot-biomechanics-in-patients-with-hallux-valgus-100624464","NCT07409974","Immediate Effect of Taping on Foot Biomechanics in Patients With Hallux Valgus","Comparison of the Immediate Effects of Kinesiological and Rigid Taping on Foot Biomechanics in Patients With Hallux Valgus","Taping in HV","Inclusion Criteria:\n\n1. Individuals aged 18-65 years\n2. Individuals with mild to moderate HV in one or both feet\n3. HV patients who do not require\u002Fare not suitable for surgery or who refuse surgery and are referred\u002Fapply for conservative treatment\n4. Individuals who have not engaged in any strenuous exercise or activity (such as running, walking, weight or resistance training, yoga, pilates, aerobics, step, etc.) in the last 2 days before evaluation.\n\nExclusion Criteria:\n\n1. The presence of contraindications for the use of the tapes (skin lesions, wounds, fungal infections, allergic reactions, sensory loss, etc.).\n2. Diagnosis of diabetic foot.\n3. Complete loss of hallux mobility, presence of interdigital neuroma, excessive pain and tenderness during mobility.\n4. Foot posture in advanced pronation or supination.\n5. The presence of diseases or problems that may affect gait (necessity of using a walking aid, visual or hearing impairment, other problems related to the lower extremity or spine).\n6. Having experienced orthopedic trauma or surgery involving the lower extremity.\n7. The presence of severe shortness of breath or inability to tolerate walking while walking.\n8. The person's; 9. Having a medical history that increases the risk of falls, such as unexplained fainting, blood sugar imbalance, unstable low or high blood pressure.\n\n10\\. Having an orthopedic or rheumatological disease (rheumatoid arthritis, gout, etc.) or a systemic disease associated with diabetes or connective tissue disorder.\n\n11\\. Being pregnant or in the first 6 months postpartum. 12. Having cooperation problems to the extent that one cannot understand and comply with the assessment protocols.",{"count":314,"type":21},30,[24],"The goal of this clinical trial is to comparatively investigate the immediate effects of rigid taping and kinesiological taping applications on foot biomechanics in patients with hallux valgus (HV). The main questions it aims to answer are:\n\nWhich taping approach (rigid or kinesiology) produces the most effective and fastest treatment response in the management of hallux valgus?\n\nResearchers will compare two taping methods to investigate which method offers a more effective and faster treatment response in terms of foot biomechanics.\n\nParticipants will:\n\n1. Individuals aged 18-65 years\n2. Individuals with mild to moderate HV in one or both feet\n3. HV patients who do not require\u002Fare not suitable for surgery or who refuse surgery and are referred\u002Fapply for conservative treatment\n4. Individuals who have not engaged in any strenuous exercise or activity (such as running, walking, weight or resistance training, yoga, pilates, aerobics, step, etc.) in the last 2 days before evaluation.",[27],"2026-02-07",{"date":320,"type":32},"2026-02-13",{"date":322,"type":21},"2026-02-15",{"date":324,"type":21},"2027-03-15",{"name":326,"class":39},"Hacettepe University",{"id":328,"slug":329,"hasResults":11,"nctId":330,"briefTitle":331,"officialTitle":332,"acronym":4,"eligibilityCriteria":333,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":97,"enrollmentInfo":334,"targetDuration":4,"studyType":22,"phases":336,"briefSummary":337,"conditions":338,"keywords":342,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":346,"lastUpdatePostDateStruct":347,"startDateStruct":349,"completionDateStruct":351,"leadSponsor":353,"locationsCount":40},"100619396","comparing-outcomes-using-1-versus-2-kirshner-wire-fixation-in-patients-with-severe-hallux-valgus-100619396","NCT07344077","Comparing Outcomes Using 1 Versus 2 Kirshner Wire Fixation in Patients With Severe Hallux Valgus","Comparison of Radiographic and Functional Outcomes of Minimal Invasive Distal Metatarsal Osteotomy Using 1 Versus 2 Kirshner Wire Fixation in Patients With Severe Hallux Valgus: A Randomized Controlled Trial","Inclusion Criteria:\n\n* age 18-60 year\n* pain along medial surface of first MTP joint\n* radiographic finding : medial deviation of first Metatarsal bone , and lateral deviation of Big toe\n* complete a follow up period of 1 year , filling questionaires and undergone radiographic examination every visit\n* radiographic finding : Hallux valgus angle \\>20 , Intermetatarsal angle \\> 10 degrees\n* failed conservative treatment for atleast 8 months , with persistent pain along medial eminence and having difficulty walking, bearing weight\n\nExclusion Criteria:\n\n* previous injury\u002Ffracture at big toe\n* deviation\u002F subluxation of 1st MTP joint from traumatic event\n* arthritic change of metatarsal bone, phalangeal bone of big toe\n* previous\u002Factive infection , open wound along first metatarsal and big toe\n* patient denied enrolling in study",{"count":335,"type":21},50,[24],"Comparing the radiographic and functional outcomes by using a Minimal invasive procedure to treat Hallux Valgus ; Distal linear Metatarsal Osteotomy -\n\n1 Kirshner wire fixation versus two Kirshner wire fixation",[339,27,340,341],"Hallux Valgus Correction","Hallux Valgus Deformity","Minimal Invasive Surgery",[343,344,345],"DLMO","kirshner wire fixation","minimal invasive surgery","2026-01-07",{"date":348,"type":32},"2026-01-15",{"date":350,"type":32},"2024-06-01",{"date":352,"type":21},"2026-05-01",{"name":354,"class":39},"Queen Savang Vadhana Memorial Hospital, Thailand",{"id":356,"slug":357,"hasResults":11,"nctId":358,"briefTitle":359,"officialTitle":359,"acronym":360,"eligibilityCriteria":361,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":362,"targetDuration":4,"studyType":22,"phases":363,"briefSummary":364,"conditions":365,"keywords":366,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":369,"lastUpdatePostDateStruct":370,"startDateStruct":372,"completionDateStruct":374,"leadSponsor":376,"locationsCount":40},"100613481","evaluation-of-a-new-postoperative-dressing-after-hallux-valgus-surgery-100613481","NCT07267156","Evaluation of a New Postoperative Dressing After Hallux Valgus Surgery","psmt3D","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Diagnosis of hallux valgus requiring surgical correction\n* Undergoing a standard hallux valgus procedure at the study center\n* Able to comply with study procedures and follow-up visits\n* Signed informed consent obtained before participation\n\nExclusion Criteria:\n\n* Inability to provide informed consent\n* Inability to comply with study procedures or follow-up visits\n* Insufficient language comprehension for study instructions\n* Bilateral hallux valgus surgery planned\n* Known allergy or hypersensitivity to thermoplastic polyurethane (TPU)",{"count":154,"type":21},[24],"Hallux valgus, commonly known as a bunion, is a condition where the big toe deviates toward the other toes, often causing pain, difficulty with footwear, and decreased quality of life. Surgery can correct the alignment of the big toe, but during recovery the toes must be supported in the correct position so that the improvement is maintained. After this surgery, a spacer is usually placed between the big toe and the second toe for several weeks while the soft tissues heal.\n\nStandard spacers made of folded gauze are not custom-shaped to each patient's foot, which may lead to discomfort, skin irritation, or misalignment of the other toes. To address these limitations, a new custom-made spacer has been developed using 3D printing technology. This spacer is individually designed to match each patient's foot shape, with the goal of improving comfort and maintaining proper toe alignment throughout the healing phase.\n\nThis clinical study will evaluate whether the custom-made 3D-printed spacer is better tolerated by patients than the traditional folded-gauze spacer and whether it helps maintain the corrected position of the big toe after surgery. The study will include 40 adults undergoing bunion surgery. Participants will be randomly assigned, like drawing lots, to receive either the 3D-printed spacer or the standard gauze spacer. Both spacers are applied externally during surgery and are worn continuously for five weeks as part of routine postoperative care.\n\nParticipants will attend follow-up visits at 1 week, 3 weeks, and 5 weeks after surgery. At each visit, comfort, pain, and any skin irritation caused by the spacer will be evaluated. At the final visit, toe alignment will be assessed using routine weight-bearing X-rays and clinical examination. No additional medical procedures or radiation will be required beyond standard care.\n\nThe hypothesis of this study is that the custom 3D-printed spacer will be well tolerated and will help maintain better toe alignment compared with the standard folded-gauze spacer. If successful, this personalized approach may improve recovery and patient satisfaction after bunion surgery.",[27],[367,368],"Hallux valgus","Postoperative dressing","2025-12-11",{"date":371,"type":32},"2025-12-17",{"date":373,"type":21},"2025-12-15",{"date":375,"type":21},"2027-04-15",{"name":377,"class":39},"Centre Assal for Foot Medicine and Surgery SA",{"id":379,"slug":380,"hasResults":11,"nctId":381,"briefTitle":382,"officialTitle":383,"acronym":4,"eligibilityCriteria":384,"healthyVolunteers":96,"sex":16,"minAge":17,"maxAge":385,"enrollmentInfo":386,"targetDuration":4,"studyType":22,"phases":388,"briefSummary":389,"conditions":390,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":391,"lastUpdatePostDateStruct":392,"startDateStruct":394,"completionDateStruct":396,"leadSponsor":398,"locationsCount":40},"100606608","acute-effects-of-prolonged-walking-on-hallux-valgus-100606608","NCT07177768","Acute Effects of Prolonged Walking on Hallux Valgus","Acute Effects of Prolonged Walking on Pain, Balance and Posture in Individuals With Hallux Valgus Deformity","Inclusion Criteria:\n\nHallux Valgus Group Criteria:\n\n* Individuals aged between 18 and 55 years\n* Being diagnosed with hallux valgus\n\nControl Group Criteria:\n\n* Individuals aged between 18 and 55 years\n* Classified as grade A according to the Manchester Scale\n* Being a volunteer\n\nExclusion Criteria:\n\n* History of previous foot or ankle surgery\n* Having a systemic diseases\n* Having a neurological disorders\n* Having a vestibular pathologies that may affect balance","55 Years",{"count":387,"type":21},32,[24],"Hallux valgus is a progressive foot deformity characterized by lateral deviation of the great toe and medial displacement of the first metatarsal head. While pain is a common symptom among individuals with HV, alterations in plantar pressure distribution and impaired balance are also frequently observed. These symptoms and biomechanical changes can negatively impact posture and gait mechanics. The aim of this study is to investigate the acute effects of prolonged walking on pain, balance, posture, and gait in individuals with hallux valgus deformity.",[27],"2025-09-10",{"date":393,"type":32},"2025-09-17",{"date":395,"type":21},"2025-10",{"date":397,"type":21},"2026-04",{"name":399,"class":39},"Bezmialem Vakif University",{"id":401,"slug":402,"hasResults":11,"nctId":403,"briefTitle":404,"officialTitle":405,"acronym":4,"eligibilityCriteria":406,"healthyVolunteers":96,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":407,"targetDuration":4,"studyType":22,"phases":409,"briefSummary":410,"conditions":411,"keywords":413,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":421,"lastUpdatePostDateStruct":422,"startDateStruct":424,"completionDateStruct":426,"leadSponsor":428,"locationsCount":40},"100480341","a-study-to-compare-early-and-partial-weight-bearing-after-hallux-valgus-surgery-100480341","NCT05534724","A Study to Compare Early and Partial Weight-bearing After Hallux Valgus Surgery","Is Full Weight Bearing After the Modified Lapidus Operation Possible? A Randomized Controlled Trial to Compare Early and Partial Weight-bearing","Inclusion Criteria:\n\n* Patient who undergo modified Lapidus arthrodesis operation and associated with:\n* Additional surgical gestures such as e.g. interventions on the proximal phalanx of the first finger (Akin) or interventions on the 2nd and \u002F or 3rd ray (Weil \u002F Hohmann) \\[23,24\\].\n* Willingness and ability to participate in the trial\n* Signed Informed Consent\n\nExclusion Criteria:\n\n* Diabetes mellitus\n* Rheumatoid arthritis\n* Previous foot surgery\n* Classic Lapidus surgery\n* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, general physical problem of the participant, etc.\n* Inability or contraindications to undergo the investigated intervention\n* Pregnant women",{"count":408,"type":21},122,[24],"This is a two-arm randomized controlled trial with the aim to evaluate the effectiveness and safety of post-operative management after a modified Lapidus arthrodesis with\u002Fwithout an Akin or a Weil\u002FHohmann surgery fusion with immediate complete weight-bearing compared with partial weight-bearing (10 - 15kg) for 6 weeks as a novel approach for rehabilitation after a foot surgery.",[27,412],"Orthopedic Disorder",[414,415,416,417,418,419,420],"Quality of life","Bone consolidation","Foot surgery","Lapidus surgery","Weil surgery","Hohmann surgery","Akin surgery","2025-08-05",{"date":423,"type":32},"2025-08-06",{"date":425,"type":32},"2023-01-19",{"date":427,"type":21},"2026-07-01",{"name":429,"class":39},"Ente Ospedaliero Cantonale, Bellinzona",{"id":431,"slug":432,"hasResults":11,"nctId":433,"briefTitle":434,"officialTitle":434,"acronym":435,"eligibilityCriteria":436,"healthyVolunteers":96,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":437,"targetDuration":4,"studyType":22,"phases":438,"briefSummary":439,"conditions":440,"keywords":445,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":455,"lastUpdatePostDateStruct":456,"startDateStruct":458,"completionDateStruct":460,"leadSponsor":462,"locationsCount":40},"100596283","comparison-of-the-immediate-effects-of-mobilization-and-manipulation-versus-sham-manipulation-on-plantar-pressure-in-patients-with-hallux-valgus-100596283","NCT07043439","Comparison of the Immediate Effects of Mobilization and Manipulation Versus Sham Manipulation on Plantar Pressure in Patients With Hallux Valgus","HALLPRESS","Inclusion Criteria:\n\n* Be over 18 years of age\n* Volunteer to participate in the study\n* Have hallux valgus (those with a hallux valgus angle greater than 15 and a Manchester Scale score of B or higher)\n\nExclusion Criteria:\n\n* Having undergone surgery on the foot or ankle area within the last 6 months\n* Having any neurological or psychiatric problems",{"count":124,"type":21},[24],"The aim of this study is to examine the immediate effects of mobilization and manipulation versus sham manipulation on plantar pressure, quality of life, and pain in patients with hallux valgus. Participants will be assessed using a sociodemographic data form, the Manchester-Oxford Foot Questionnaire (MOXFQ), the Manchester Scale, goniometric measurements, the Multidimensional Nil Hallux Valgus Scale, the SF-36 Health Survey, the Numeric Pain Rating Scale (NPRS), and plantar pressure analysis via a pedobarographic device. The study will be conducted on a total of 60 feet, with 30 feet assigned to the manipulation group and 30 feet to the sham manipulation group.",[27,274,441,442,443,444],"Musculoskeletal Manipulations","Plantar Pressure","Manuel Therapy","Chiropractic",[27,446,447,448,449,450,451,452,453,454],"First Metatarsal Mobilization","HVLA Manipulation","Sham Manipulation","Plantar Pressure Analysis","Pedobarography","Manual Therapy","Chiropractic Mobilization","Pain","Quality of Life","2025-06-20",{"date":457,"type":32},"2025-06-29",{"date":459,"type":21},"2025-06-25",{"date":461,"type":21},"2025-08-25",{"name":463,"class":39},"SEFA HAKTAN HATIK",{"id":465,"slug":466,"hasResults":11,"nctId":467,"briefTitle":468,"officialTitle":469,"acronym":470,"eligibilityCriteria":471,"healthyVolunteers":96,"sex":16,"minAge":472,"maxAge":152,"enrollmentInfo":473,"targetDuration":4,"studyType":22,"phases":475,"briefSummary":476,"conditions":477,"keywords":479,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":246,"lastUpdatePostDateStruct":480,"startDateStruct":482,"completionDateStruct":484,"leadSponsor":486,"locationsCount":488},"100484402","outcomes-following-combined-adductoplasty-and-lapiplasty-mta3d-100484402","NCT05587569","Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)","Radiographic and Patient Reported Outcomes Following Combined Adductoplasty™ and Lapiplasty® Procedures for Correction of Metatarsus Adductus and Hallux Valgus (MTA3D)","MTA3D","Inclusion Criteria:\n\n1. Male and females ≥14 years old at the time of consent\n2. Closed physeal plates at the time of consent\n3. Intermetatarsal angle is ≥8.0˚; OR True IMA of \\>10°, (IMA+MTA-15=True IMA)\n4. Hallux valgus angle is ≥12.0˚\n5. Metatarsus adductus angle based on Sgarlatos method ≥15°\n6. Willing and able to adhere to post-op care instructions\n7. Capable of completing self-administered questionnaires\n8. Acceptable surgical candidate, including use of general anesthesia\n9. Female patients must be of non-childbearing potential or have a negative pregnancy test in accordance with hospital standards prior to the Index Procedure\n10. Willing and able to schedule index procedure within 3 months of consent and able to return for scheduled follow-up visits\n11. Willing and able to provide written informed consent\n12. Patient agrees to refrain from any reconstructive procedures on contralateral foot for minimum of 6 months post index procedure\n\nExclusion Criteria:\n\n1. Previous surgery for hallux valgus on operative side\n2. Previous surgeries on operative foot involving fusion of foot or ankle joints (other than hammertoe, lesser toes\u002Fdigits, or posterior muscle lengthening)\n3. Moderate-severe osteoarthritis of the foot or ankle outside of the 1st, 2nd or 3rd tarsometatarsal joints\n4. Severe osteoarthritis of the 1st, 2nd or 3rd tarsometatarsal joints\n5. Any deformity of the hindfoot or midfoot that represents a pathological condition that may affect the outcome of the tarsometatarsal realignment, or a condition that requires concomitant surgical correction\n6. BMI \\>40 kg\u002Fm²\n7. Current nicotine user in any form including vaping, smoking, oral ingestion or use of nicotine patch\n8. Current clinical diagnosis of diabetes or currently taking medication for treatment of diabetes\n9. Current clinical diagnosis of peripheral neuropathy\n10. Current clinical diagnosis of fibromyalgia\n11. Current clinical diagnosis of Complex Regional Pain Syndrome\u002FReflex Sympathetic Dystrophy (CRPS\u002FRSD)\n12. Current uncontrolled hypothyroidism\n13. Current clinical diagnosis of chronic dependent edema\n14. Previously sensitized to titanium\n15. Currently taking oral steroids or rheumatoid biologics\n16. Currently taking immunosuppressant drugs\n17. Insufficient quantity or quality of bone to permit stabilization, conditions that inhibit healing (not including pathological fractures) and conditions causing poor blood supply such as peripheral vascular disease\n18. Active, suspected, or latent infection in the affected area\n19. Use of synthetic or allogenic bone graft substitutes\n20. Use of non-Treace products for Index Procedure\n21. Additional bone procedure needed during the index procedure to complete correction \\[first MTP fusion, calcaneal osteotomy, traditional medial eminence resection, additional metatarsal or tarsal bone osteotomy or fusion (other than Weil osteotomies)\\];\n22. Scheduled to undergo a same-day bilateral procedure\n23. Patient has previously been enrolled into this study for a contralateral procedure\n24. Scheduled for any concomitant procedure that would alter patient's ability to weight-bear post-procedure\n25. Patient is actively involved with a workman's compensation case or is currently involved in litigation\n26. Patient is currently in, or has participated in, a clinical study in the last 30 days prior to signing informed consent or is considering participation in another research protocol during this study. Exceptions to this include survey clinical studies with no treatment or if subject is greater than 12 months post procedure in either the Treace ALIGN3D™ or Mini3D™ Study without ongoing protocol defined AE\n27. Patient has a condition or finding that, in the opinion of the Investigator, may jeopardize the patient's well-being, the soundness of this clinical study, or could interfere with provision of informed consent, completion of tests, therapy, or follow-up","14 Years",{"count":474,"type":21},80,[24],"Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction.\n\nUp to 80 subjects will be treated in this study at up to 13 clinical sites. Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion and exclusion criteria defined in the study protocol.",[478,27],"Metatarsus Adductus",[478,27,470],{"date":481,"type":32},"2025-05-25",{"date":483,"type":32},"2022-09-28",{"date":485,"type":21},"2030-12-31",{"name":487,"class":65},"Treace Medical Concepts, Inc.",9,{"id":490,"slug":491,"hasResults":11,"nctId":492,"briefTitle":493,"officialTitle":494,"acronym":4,"eligibilityCriteria":495,"healthyVolunteers":11,"sex":16,"minAge":97,"maxAge":496,"enrollmentInfo":497,"targetDuration":498,"studyType":52,"phases":4,"briefSummary":499,"conditions":500,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":501,"lastUpdatePostDateStruct":502,"startDateStruct":504,"completionDateStruct":506,"leadSponsor":508,"locationsCount":40},"100583299","second-toe-length-and-hallux-valgus-greek-vs-egyptian-foot-100583299","NCT06874517","Second Toe Length and Hallux Valgus: Greek vs. Egyptian Foot","Greek vs. Egyptian Foot: The Impact of Second Toe Length on Hallux Valgus Development","Inclusion Criteria:\n\n* Age between 60-80 years\n* Presence of foot radiographs suitable for measurement\n* No history of prior foot surgery\n\nExclusion Criteria:\n\n* History of foot trauma or fractures\n* Previous foot or toe surgery\n* Presence of congenital foot deformities\n* Neurological or rheumatologic conditions affecting foot structure\n* Severe osteoarthritis or other degenerative foot diseases visible on radiographs","80 Years",{"count":99,"type":21},"1 Day","A total of 150 patients aged 60-80 years with existing foot radiographs will be included in the study. Radiographic evaluations will include measurements of the hallux valgus angle, first intermetatarsal angle, and the metatarsal and phalanx lengths of the first and second toes. The ratio of the second toe phalanx length to the first toe phalanx length will be calculated and recorded. The relationship between the hallux valgus angle, toe lengths, and their ratios will be analyzed using statistical methods.",[27],"2025-03-22",{"date":503,"type":32},"2025-03-26",{"date":505,"type":32},"2025-03-10",{"date":507,"type":21},"2025-04-10",{"name":509,"class":39},"Beylikduzu State Hospital",{"id":511,"slug":512,"hasResults":11,"nctId":513,"briefTitle":514,"officialTitle":515,"acronym":4,"eligibilityCriteria":516,"healthyVolunteers":11,"sex":16,"minAge":517,"maxAge":97,"enrollmentInfo":518,"targetDuration":4,"studyType":22,"phases":520,"briefSummary":521,"conditions":522,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":505,"lastUpdatePostDateStruct":524,"startDateStruct":526,"completionDateStruct":528,"leadSponsor":529,"locationsCount":40},"100417473","prospective-study-the-effect-on-clinical-outcome-after-treatment-of-mtp-cartilage-lesions-in-hallux-valgus-surgery-100417473","NCT04716140","Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery","Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions","Inclusion Criteria:\n\n* hallux valgus\n\nExclusion Criteria:\n\n* younger than 30 years, older than 60 years\n* extra pathologies other than hallux valgus","30 Years",{"count":519,"type":21},99,[24],"The aim of this study is to investigate the point or nonsense of treating cartilage lesions at the level of the first metatarsophalane joint. To date, no clear guidelines have been found in the literature with regard to the treatment of cartilage lesions at the MTP I joint during corrective surgery for hallux valgus, nor has it been investigated whether this can have an effect on the clinical outcome.",[27,523],"Cartilage Damage",{"date":525,"type":32},"2025-03-12",{"date":527,"type":32},"2020-09-15",{"date":163,"type":21},{"name":530,"class":39},"Tom Lootens",{"id":532,"slug":533,"hasResults":11,"nctId":534,"briefTitle":535,"officialTitle":536,"acronym":4,"eligibilityCriteria":537,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":538,"targetDuration":4,"studyType":22,"phases":540,"briefSummary":541,"conditions":542,"keywords":543,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":545,"lastUpdatePostDateStruct":546,"startDateStruct":548,"completionDateStruct":550,"leadSponsor":552,"locationsCount":40},"100398825","the-effect-of-weight-bearing-on-patient-outcomes-following-1st-mtp-joint-fusion-100398825","NCT04473196","The Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion","Prospective, Randomized Trial to Evaluate the Effect of Weight Bearing on Patient Outcomes Following 1st MTP Joint Fusion","Inclusion Criteria:\n\n* Age 18 years or great\n* Medically fit for surgery\n* Patients diagnosed with condition for which a 1st MTP joint fusion is a surgical management option based on clinical examination and radiographs\n* Failed non-operative management (orthotics, bracing, Tylenol, NSAIDs, shoe-wear modification)\n* Surgery is for an isolated 1st MTP fusion\n* Able and willing to comply with follow up schedule and requirements\n* Capable of providing informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C18 years old\n* Surgical booking is for more than just 1st MTP fusion\n* Unable to comply with follow up schedule and requirements\n* Unable to provide informed consent",{"count":539,"type":21},92,[24],"randomized-controlled trial looking specifically at the effect of weight bearing on the outcomes of first MTP joint fusions",[27,102],[544],"MTP Hallux rigidus Osteoarthritis","2024-08-21",{"date":547,"type":32},"2024-08-23",{"date":549,"type":32},"2020-09-30",{"date":551,"type":21},"2026-08-31",{"name":553,"class":39},"Nova Scotia Health Authority",{"id":555,"slug":556,"hasResults":11,"nctId":557,"briefTitle":558,"officialTitle":559,"acronym":4,"eligibilityCriteria":560,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":97,"enrollmentInfo":561,"targetDuration":4,"studyType":22,"phases":562,"briefSummary":563,"conditions":564,"keywords":565,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":571,"lastUpdatePostDateStruct":572,"startDateStruct":574,"completionDateStruct":576,"leadSponsor":578,"locationsCount":40},"100557669","effect-of-selective-strengthening-of-peroneus-longus-on-pain--joint-alignment-and-foot-function-in-hallux-valgus-100557669","NCT06541119","Effect of Selective Strengthening of Peroneus Longus on Pain , Joint Alignment and Foot Function in Hallux Valgus","Effect of Selective Strengthening of Peroneus Longus Muscles on Pain Joint Alignment and Foot Function in Hallux Valgus","Inclusion Criteria:\n\n* All patients must be diagnosed as having mild to moderate Hallux valgus (with Hallux valgus angle between 15-40 degrees)\n* patients aging between 18-60 .\n* patients must report pain and limited function .\n* patients must report that they are not undergoing physiotherapy , not using orthosis , dynamic splinting exercises for Hallux valgus\n\nExclusion Criteria:\n\n* Patients diagnosed with systematic diseases such as rheumatoid arthritis .\n* Cognitive or mental illness.\n* Hallux rigidus or limitus .\n* History of surgery to foot of Hallux .\n* Previous use of foot orthosis .",{"count":124,"type":21},[24],"Purpose of this study is to measure Change in Hallux valgus angle (HVA )as measured by kinovea software Change in pain as measured by numerical pain rating scale (NPRS) Change in function as measured by Foot function index (FFI )Egyptian version With the peroneus longus strengthening exercise versus the use of conventional physical therapy programme in cases of hallux valgus patients",[27],[566,567,568,569,570],"Peroneus longus","Hallux valgus angle HVA","Kinovea software","Foot function index","Hallux pain","2024-08-09",{"date":573,"type":32},"2024-08-12",{"date":575,"type":21},"2024-09-01",{"date":577,"type":21},"2024-11-15",{"name":579,"class":39},"Cairo University",{"id":581,"slug":582,"hasResults":11,"nctId":583,"briefTitle":584,"officialTitle":585,"acronym":4,"eligibilityCriteria":586,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":587,"targetDuration":4,"studyType":52,"phases":4,"briefSummary":589,"conditions":590,"keywords":591,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":594,"lastUpdatePostDateStruct":595,"startDateStruct":597,"completionDateStruct":599,"leadSponsor":601,"locationsCount":40},"100427840","hallux-valgus--radiological-and-clinical-predictors-for-outcome-after-surgery-100427840","NCT04851249","Hallux Valgus- Radiological and Clinical Predictors for Outcome After Surgery","Hallux Valgus - Radiological and Clinical Predictors for Outcome After Surgery","Inclusion Criteria:\n\n* All adult patients accepted for hallux valgus surgery (mild, moderate, severe) at the ØHT will be asked to participate in the study\n\nExclusion Criteria:\n\n* Previous hallux valgus surgery in the same foot\n* Lack of compliance\n* Not available for follow-up\n* Language difficulties (not able to communicate in English or Norwegian)",{"count":588,"type":21},250,"Prospective observational study to evaluate the clinical and radiological predictors for outcome in hallux valgus (HV) corrective surgery.",[27],[367,592,593],"Outcome predictors","MOXFQ","2024-07-09",{"date":596,"type":32},"2024-07-10",{"date":598,"type":32},"2022-01-01",{"date":600,"type":21},"2027-12-01",{"name":602,"class":39},"Ostfold Hospital Trust"]